Eco Fusion
Personalized Neuro-digital Therapeutics Platform
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
Eco Fusion | 02/07/2022 | NeuroreHabilitation | NeuroDegenerative | NeuralProstheses | Digital & Health care | Clinical use (of cognitive, psychological, psychiatric, inc. early diagnosis) | Software Development | Apps | 01/01/2014 | "1-10" |
Eco-Fusion is an AI-driven digital therapeutics company offering a flexible and patented closed-loop mobile platform to address a variety of chronic and mental conditions. Eco-Fusion partners with pharmaceutical, health, and insurance organizations to create digital therapeutics.
The company's initial product is the award-winning Serenita, an AI-driven stress-reducing and focus-enhancing technology. Serenita has been shown to help patients with diabetes significantly reduce their blood sugar levels and lose significant weight.
Eco-Fusion's broader online platform, NewMe, uses sensor data and patient-reported data to analyze and render personalized treatments through neuro-stimulation wearables and behavioral therapies.
Combating Coronavirus Pandemic:
More than 63% of the people are experiencing depression and anxiety issues during the COVID-19 global crisis. Eco Fusion is addressing this using its patented stress relief engine. The company also uses sensor data and patient-reported data to analyze and render comprehensive personalized treatments.
The company's platform has rapidly adapted to emergency situations (such as COVID-19) where telemedicine is crucial. Eco-Fusion is also collaborating on solutions related to tracking cases and assessing COVID-19 infection risk in real-time.